The patient was started on a 2-year course ... (C) VEGFR-3, a receptor for the lymphangiogenic factor VEGF-C, is expressed by immune cells and some of the vessels. (D, E) PDGFR-β is expressed ...
Expert Rev Anticancer Ther. 2009;9(6):839-849. BAY43-9006 (Sorafenib) Small-molecule inhibitor BRAF, EGFR, c-kit, PDGFR, VEGFR-2 and 3 Phase II-III (in combination with chemotherapy) TKI258 (CHIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback